Drug company (FDA labeler)
Radha Pharmaceuticals, Inc.
NDC labeler code: 77771
What is a labeler?
The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.
Official FDA data only
Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.
Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.
Prescription medicines
- BupropionWellbutrin SR, Aplenzin, Wellbutrin XL · 5 products
- BuspironeBucapsol · 5 products
- Hydralazine hydrochloride4 products
- CelecoxibCelebrex, Vyscoxa, Elyxyb - Celecoxib · 4 products
- FluconazoleDiflucan · 4 products
- AtorvastatinLipitor · 4 products
- NaproxenNaprelan, Rugby All Day Relief · 3 products
- FluoxetineProzac · 3 products
- RanolazineAspruzyo Sprinkle · 2 products
- GabapentinNeurontin, Gralise, Relgaabi · 2 products
- ClopidogrelPlavix · 2 products
- TicagrelorBrilinta · 2 products
- Carbidopa and levodopaCrexont, Rytary, Sinemet · 2 products
- TofacitinibXeljanz, Xeljanz XR · 1 product
FDA applications for these products
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Approved | Application | Medicine | Sponsor |
|---|---|---|---|
| June 25, 2026 | ANDA220972 | Tofacitinib TOFACITINIB CITRATE | Sciegen Pharms |
| October 28, 2025 | ANDA218962 | Ticagrelor TICAGRELOR | Sciegen Pharms |
| October 5, 2021 | ANDA214091 | Carbidopa and levodopa CARBIDOPA AND LEVODOPA | Sciegen Pharms |
| December 3, 2020 | ANDA205129 | Celecoxib CELECOXIB | Sciegen Pharms |
| February 21, 2020 | ANDA212517 | Naproxen NAPROXEN | Sciegen Pharms |
| June 4, 2019 | ANDA211829 | Ranolazine RANOLAZINE | Sciegen Pharms |
| May 26, 2017 | ANDA205236 | Hydralazine hydrochloride HYDRALAZINE HYDROCHLORIDE | Sciegen Pharms |
| April 12, 2017 | ANDA207479 | Bupropion BUPROPION HYDROCHLORIDE | Sciegen Pharms |
| May 19, 2016 | ANDA205519 | Atorvastatin ATORVASTATIN CALCIUM | Sciegen Pharms |
| March 1, 2016 | ANDA205794 | Bupropion BUPROPION HYDROCHLORIDE | Sciegen Pharms |
| February 4, 2016 | ANDA205101 | Gabapentin GABAPENTIN | Sciegen Pharms |
| December 16, 2015 | ANDA202087 | Buspirone BUSPIRONE HYDROCHLORIDE | Aiping Pharm Inc |
| March 16, 2015 | ANDA204597 | Fluoxetine FLUOXETINE HYDROCHLORIDE | Sciegen Pharms |
| September 15, 2014 | ANDA204165 | Clopidogrel CLOPIDOGREL BISULFATE | Sciegen Pharms |
| January 25, 2006 | ANDA077253 | Fluconazole FLUCONAZOLE | Glenmark Pharms Ltd |
The sponsor is the company that holds the FDA application; it can differ from the labeler.
Recall timeline
No recall of these products (by NDC code) appears in the FDA enforcement reports.
Next steps
- Find a pharmacy near youAsk which company made your medicine and whether it is recalled
- Latest FDA drug recallsAll companies, newest first
- All drug companiesA to Z
- All prescription drugs A to ZSearch by generic, brand or Spanish name
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026